VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Saturday, January 3, 2026
Stock Comparison
L3Harris Technologies, Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
L3Harris Technologies, Inc.
LHX · NYSE
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into L3Harris Technologies, Inc.'s moat claims, evidence, and risks.
View LHX analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 72 / 100 for L3Harris Technologies, Inc.).
- Segment focus: L3Harris Technologies, Inc. has 4 segments (31.9% in Space & Airborne Systems); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Moat breadth: L3Harris Technologies, Inc. has 8 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
L3Harris Technologies, Inc.
Space & Airborne Systems
Defense & intelligence space and airborne mission systems (payloads, sensors, avionics, mission networks)
Global (U.S.-centric demand)
Government defense/intelligence agencies, prime contractors, and allied governments
Prime contractor / subsystem integrator
31.9%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
L3Harris Technologies, Inc. strengths
Sanofi strengths
Segment mix
L3Harris Technologies, Inc. segments
Full profile >Space & Airborne Systems
Oligopoly
Integrated Mission Systems
Oligopoly
Communication Systems
Oligopoly
Aerojet Rocketdyne
Duopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.